Klin Monbl Augenheilkd 2011; 228(7): 586-592
DOI: 10.1055/s-0031-1273474
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Intraokulare Manifestationen bei systemischen Tumorerkrankungen

Intraocular Manifestations of Systemic NeoplasmsN. E. Bechrakis1 , G. Haas1 , G. Blatsios1
  • 1Department of Ophthalmology, Innsbruck Medical University, Innsbruck, Austria
Further Information

Publication History

Eingegangen: 14.4.2011

Angenommen: 10.6.2011

Publication Date:
07 July 2011 (online)

Zusammenfassung

Bei Patienten mit systemischen Tumorerkrankungen besteht eine Vielzahl von möglichen intraokulären Manifestationen. An erster Stelle stehen Metastasen in die Aderhaut, Retina und den Glaskörper von Karzinomen, Melanomen und Lymphomen. Beim von-Hippel-Lindau-Syndrom, der familiären adenomatösen Polyposis coli (FAP), dem Gardner- und Turcot-Syndrom ist die ophthalmologische Primärdiagnostik grundlegend für die Einleitung von Screening-Untersuchungen zum Ausschluss von systemischen Neoplasien (zerebelläres, spinales Hämangioblastom bzw. Nierenzell- und Kolonkarzinom) erforderlich. Weiters gibt es eine Reihe von seltenen paraneoplastischen Syndromen wie die tumor- bzw. melanomassoziierte Retinopathie (CAR, MAR), der paraneoplastischen Optikusneuropathie (PON) sowie die bilaterale diffuse uveale melanozytäre Proliferation (BDUMP), deren Therapien jedoch meistens limitiert und frustran sind.

Abstract

There are multiple possible intraocular manifestations in patients with systemic neoplasms. At first line there are uveal, retinal and vitreous metastases from carcinomas, melanomas and lymphomas. In patients with von Hippel Lindau syndrome or familiar adenomatous polyposis coli (FAP), Gardner or Turcot syndromes, fundus examinations can help in the primary diagnosis and thereby facilitate the early detection of systemic neoplasms such as cerebral and spinal haemangioblastoma, kidney or bowel cancer. Furthermore there are rare ocular paraneoplastic syndromes such as the cancer- or melanoma-associated retinopathies (CAR/MAR), the paraneoplastic optic neuropathy (PON) and the bilateral diffuse melanocytic proliferation (BDUMP) that develop secondary to systemic malignancies and can be the primary manifestation.

Literatur

  • 1 Kreusel K M, Bechrakis N, Wiegel T et al. Clinical characteristics of choroidal metastasis.  Ophthalmologe. 2003;  100 618-622
  • 2 Shields C L, Shields J A, Gross N E et al. Survey of 520 eyes with uveal metastases.  Ophthalmology. 1997;  104 1265-1276
  • 3 Alm A, Bill A, Young F A. The effects of pilocarpine and neostigmine on the blood flow through the anterior uvea in monkeys. A study with radioactively labelled microspheres.  Experimental eye research. 1973;  15 31-36
  • 4 Lee J, Lee S, Sohn J et al. Clinical features of uveal metastases in Korean patients.  Retina. 2003;  23 491-494
  • 5 Wiegel T, Kreusel K M, Bornfeld N et al. Frequency of asymptomatic choroidal metastasis in patients with disseminated breast cancer: results of a prospective screening programme.  The British journal of ophthalmology. 1998;  82 1159-1161
  • 6 Demirci H, Shields C L, Chao A N et al. Uveal metastasis from breast cancer in 264 patients.  American journal of ophthalmology. 2003;  136 264-271
  • 7 Lemke A J, Hosten N, Wiegel T et al. Intraocular metastases: differential diagnosis from uveal melanomas with high-resolution MRI using a surface coil.  Eur Radiol. 2001;  11 2593-2601
  • 8 Lemke A J, Hosten N, Bornfeld N et al. Uveal melanoma: correlation of histopathologic and radiologic findings by using thin-section MR imaging with a surface coil.  Radiology. 1999;  210 775-783
  • 9 Krause L, Bechrakis N E, Kreusel K M et al. Indocyanine green angiography in choroid metastases.  Ophthalmologe. 2002;  99 617-619
  • 10 Natesh S, Chin K J, Finger P T. Choroidal Metastases Fundus Autofluorescence Imaging: Correlation to Clinical, OCT, and Fluorescein Angiographic Findings.  Ophthalmic Surg Lasers Imaging. 2010;  in press, online first
  • 11 Ishida T, Ohno-Matsui K, Kaneko Y et al. Fundus autofluorescence patterns in eyes with primary intraocular lymphoma.  Retina. 2010;  30 23-32
  • 12 Perez-Alvarez M J, Arriola-Villalobos P, Reche-Frutos J et al. Choroidal metastasis from a breast carcinoma. Diagnosis and follow-up with optical coherence tomography and fluorescein angiography and autofluorescence with HRA-II (Heidelberg Retina Angiograph).  Arch Soc Esp Oftalmol. 2009;  84 267-270
  • 13 Collet L C, Pulido J S, Gunduz K et al. Fundus autofluorescence in choroidal metastatic lesions: a pilot study.  Retina. 2008;  28 1251-1256
  • 14 Ishida T, Ohno-Matsui K, Kaneko Y et al. Autofluorescence of metastatic choroidal tumor.  Int Ophthalmol. 2009;  29 309-313
  • 15 Bechrakis N E, Foerster M H, Bornfeld N. Biopsy in indeterminate intraocular tumors.  Ophthalmology. 2002;  109 235-242
  • 16 Eide N, Syrdalen P, Walaas L et al. Fine needle aspiration biopsy in selecting treatment for inconclusive intraocular disease.  Acta Ophthalmol Scand. 1999;  77 448-452
  • 17 Fastenberg D M, Finger P T, Chess Q et al. Vitrectomy retinotomy aspiration biopsy of choroidal tumors.  American journal of ophthalmology. 1990;  110 361-365
  • 18 Foulds W S. The uses and limitations of intraocular biopsy.  Eye. 1992;  6 (Pt 1) 11-27
  • 19 Foulds W S, Lee W R, Roxburgh S T et al. Can chorio-retinal biopsy be justified?.  Trans Ophthalmol Soc U K. 1985;  104 (Pt 8) 864-868
  • 20 Jensen O A, Prause J U, Scherfig E. Transvitreal retino-choroidal biopsy of suspected malignant lesions of the choroid. Follow-up of cases over 7 years.  Acta Ophthalmol Scand. 1997;  75 409-411
  • 21 Johnston R L, Tufail A, Lightman S et al. Retinal and choroidal biopsies are helpful in unclear uveitis of suspected infectious or malignant origin.  Ophthalmology. 2004;  111 522-528
  • 22 Peyman G A. Vitrectomy retinotomy aspiration biopsy of choroidal tumors.  American journal of ophthalmology. 1991;  111 121
  • 23 Scherfig E, Prause J U, Jensen O A. Transvitreal retinochoroidal biopsy.  Graefe’s archive for clinical and experimental ophthalmology. 1989;  227 369-373
  • 24 Shanmugam M P, Biswas J. Fine needle aspiration biopsy in the diagnosis of intraocular mass lesions.  Indian J Ophthalmol. 1997;  45 105-108
  • 25 Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1.  Archives of ophthalmology. 1990;  108 1268-1273
  • 26 Wiegel T, Bottke D, Kreusel K M et al. External beam radiotherapy of choroidal metastases – final results of a prospective study of the German Cancer Society (ARO 95 – 08).  Radiother Oncol. 2002;  64 13-18
  • 27 Coupland S E, Damato B. Understanding intraocular lymphomas.  Clin Experiment Ophthalmol. 2008;  36 564-578
  • 28 Karma A, Willebrand E O, Tommila P V et al. Primary intraocular lymphoma: improving the diagnostic procedure.  Ophthalmology. 2007;  114 1372-1377
  • 29 Choi J Y, Kafkala von C, Foster C S. Primary intraocular lymphoma: A review.  Semin Ophthalmol. 2006;  21 125-133
  • 30 Coupland S E, Heimann H, Bechrakis N E. Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features.  Graefe’s archive for clinical and experimental ophthalmology. 2004;  242 901-913
  • 31 Chan C C, Buggage R R, Nussenblatt R B. Intraocular lymphoma.  Current opinion in ophthalmology. 2002;  13 411-418
  • 32 Coupland S E, Foss H D, Bechrakis N E et al. Secondary ocular involvement in systemic „memory” B-cell lymphocytic leukemia.  Ophthalmology. 2001;  108 1289-1295
  • 33 Gill M K, Jampol L M. Variations in the presentation of primary intraocular lymphoma: case reports and a review.  Survey of ophthalmology. 2001;  45 463-471
  • 34 Akpek E K, Ahmed I, Hochberg F H et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.  Ophthalmology. 1999;  106 1805-1810
  • 35 Gunduz K, Pulido J S, McCannel C A et al. Ocular manifestations and treatment of central nervous system lymphomas.  Neurosurg Focus. 2006;  21 E9
  • 36 Jahnke K, Korfel A, Komm J et al. Intraocular lymphoma 2000 – 2005: results of a retrospective multicentre trial.  Graefe’s archive for clinical and experimental ophthalmology. 2006;  244 663-669
  • 37 Malinowski S M. The vitreous trap: a simple, surgeon-controlled technique for obtaining undiluted vitreous and subretinal specimens during pars plana vitrectomy.  Retina. 2010;  30 828-829
  • 38 Gonzales J A, Chan C C. Biopsy techniques and yields in diagnosing primary intraocular lymphoma.  Int Ophthalmol. 2007;  27 241-250
  • 39 Coupland S E, Bechrakis N E, Anastassiou G et al. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome.  Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie. 2003;  241 860-870
  • 40 Levy-Clarke G A, Byrnes G A, Buggage R R et al. Primary intraocular lymphoma diagnosed by fine needle aspiration biopsy of a subretinal lesion.  Retina. 2001;  21 281-284
  • 41 Pavan P R, Oteiza E E, Margo C E. Ocular lymphoma diagnosed by internal subretinal pigment epithelium biopsy.  Archives of ophthalmology. 1995;  113 1233-1234
  • 42 Gordon K B, Rugo H S, Duncan J L et al. Ocular manifestations of leukemia: leukemic infiltration versus infectious process.  Ophthalmology. 2001;  108 2293-2300
  • 43 Kuwabara T. Leukemic Miliary Nodules in the Retina.  Archives of ophthalmology. 1964;  72 494-497
  • 44 Jackson N, Reddy S C, Hishamuddin M et al. Retinal findings in adult leukaemia: correlation with leukocytosis.  Clin Lab Haematol. 1996;  18 105-109
  • 45 Leach M J. Images in clinical medicine. Retinal hemorrhages in acute leukemia.  N Engl J Med. 2002;  346 e6
  • 46 Kassam F, Gale J S, Sheidow T G. Intraocular leukemia as the primary manifestation of relapsing acute myelogenous leukemia.  Canadian journal of ophthalmology. 2003;  38 613-616
  • 47 Chakraborty P P, Mandal S K, Bandyopadhyay D et al. Roth’s spots as an only sign of acute myeloid leukemia.  J Assoc Physicians India. 2006;  54 547
  • 48 Zhang Y Q, Wang W J. Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis.  Retina. 2005;  25 746-750
  • 49 Fries B C, Riddell S R, Kim H W et al. Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantation.  Biol Blood Marrow Transplant. 2005;  11 136-148
  • 50 Coskuncan N M, Jabs D A, Dunn J P et al. The eye in bone marrow transplantation. VI. Retinal complications.  Archives of ophthalmology. 1994;  112 372-379
  • 51 Allione A, Montanaro M, Marmont F et al. Fungal endophthalmitis in acute leukaemia.  Br J Haematol. 2004;  124 257
  • 52 Machado Od Ode O, Goncalves R, Fernandes E M et al. Bilateral Aspergillus endophthalmitis in a patient with chronic lymphocytic leukaemia.  The British journal of ophthalmology. 2003;  87 1429-1430
  • 53 Song W K, Min Y H, Kim Y R et al. Cytomegalovirus retinitis after hematopoietic stem cell transplantation with alemtuzumab.  Ophthalmology. 2008;  115 1766-1770
  • 54 Kerrison J B. Neuro-ophthalmology of the phacomatoses.  Current opinion in ophthalmology. 2000;  11 413-420
  • 55 Kreusel K M, Krause L, Graul-Neumann L et al. Family screening in patients with retinal angiomatosis.  Klin Monatsbl Augenheilkd. 2009;  226 939-943
  • 56 Kreusel K M, Bechrakis N E, Neumann H P et al. Solitary juxtapapillary capillary retinal angioma and von Hippel-Lindau disease.  Canadian journal of ophthalmology. 2007;  42 251-255
  • 57 Kreusel K M, Bechrakis N E, Neumann H P et al. Juxtapapillary capillary retinal angioma with epiretinal membrane of the macula in familial Von-Hippel-Lindau-Syndrome.  Ophthalmologe. 2007;  104 317-320
  • 58 Kreusel K M, Bechrakis N E, Krause L et al. Retinal angiomatosis in von Hippel-Lindau disease: a longitudinal ophthalmologic study.  Ophthalmology. 2006;  113 1418-1424
  • 59 Kreusel K M, Bechrakis N E, Heinichen T et al. Retinal angiomatosis and von Hippel-Lindau disease.  Graefe’s archive for clinical and experimental ophthalmology. 2000;  238 916-921
  • 60 Maher E R, Yates J R, Harries R et al. Clinical features and natural history of von Hippel-Lindau disease.  The Quarterly journal of medicine. 1990;  77 1151-1163
  • 61 Bisgaard M L, Bulow S. Familial adenomatous polyposis (FAP): genotype correlation to FAP phenotype with osteomas and sebaceous cysts.  Am J Med Genet A. 2006;  140 200-204
  • 62 Traboulsi E I. Ocular manifestations of familial adenomatous polyposis (Gardner syndrome).  Ophthalmol Clin North Am. 2005;  18 163-166, x
  • 63 Meyer C H, Becker R, Schmidt J C et al. When is congenital hypertrophy of the retinal pigment epithelium (CHRPE) associated with the Gardner’s syndrome? An overview with clinical examples.  Klin Monatsbl Augenheilkd. 2002;  219 644-648
  • 64 Ballhausen W G. Genetic testing for familial adenomatous polyposis.  Ann N Y Acad Sci. 2000;  910 36-47 ; discussion 47 – 39
  • 65 Tiret A, Parc C. Fundus lesions of adenomatous polyposis.  Current opinion in ophthalmology. 1999;  10 168-172
  • 66 Tiret A, Taiel-Sartral M, Tiret E et al. Diagnostic value of fundus examination in familial adenomatous polyposis.  The British journal of ophthalmology. 1997;  81 755-758
  • 67 Munden P M, Sobol W M, Weingeist T A. Ocular findings in Turcot syndrome (glioma-polyposis).  Ophthalmology. 1991;  98 111-114
  • 68 Traboulsi E I, Maumenee I H, Krush A J et al. Pigmented ocular fundus lesions in the inherited gastrointestinal polyposis syndromes and in hereditary nonpolyposis colorectal cancer.  Ophthalmology. 1988;  95 964-969
  • 69 Gomez Garcia E B, Knoers N V. Gardner’s syndrome (familial adenomatous polyposis): a cilia-related disorder.  Lancet Oncol. 2009;  10 727-735
  • 70 Jacobzone C, Cochard-Marianowski C, Kupfer I et al. Corticosteroid treatment for melanoma-associated retinopathy: effect on visual acuity and electrophysiologic findings.  Arch Dermatol. 2004;  140 1258-1261
  • 71 Adamus G. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy.  Autoimmun Rev. 2009;  8 410-414
  • 72 Ling C P, Pavesio C. Paraneoplastic syndromes associated with visual loss.  Current opinion in ophthalmology. 2003;  14 426-432
  • 73 Gass J D, Gieser R G, Wilkinson C P et al. Bilateral diffuse uveal melanocytic proliferation in patients with occult carcinoma.  Archives of ophthalmology. 1990;  108 527-533
  • 74 Brüggemann A, Bülow von M, Finas D et al. Bilateral diffuse uveal melanocytic proliferation associated with the recurrence of a Bartholin gland carcinoma.  The British journal of ophthalmology. 2011;  in press, online first
  • 75 Mandelcorn E, McGuire K, Dixon W et al. Ocular paraneoplastic syndrome: a case of bilateral diffuse uveal melanocytic proliferation.  Retina. 2009;  29 1375-1376
  • 76 Ritland J S, Eide N, Tausjo J. Bilateral diffuse uveal melanocytic proliferation and uterine cancer. A case report.  Acta Ophthalmol Scand. 2000;  78 366-368

Prof. Dr. Nikolaos E. Bechrakis

Direktor der Univ.-Augenklinik, Medizinische Universität Innsbruck

Anichstr. 35

6020 Innsbruck

Österreich

Phone: ++ 43/5 12/50 42 37 20

Fax: ++ 43/5 12/50 42 37 22

Email: nikolaos.bechrakis@i-med.ac.at

    >